XML 16 R13.htm IDEA: XBRL DOCUMENT v3.20.1
Equity and Earnings Per Share
3 Months Ended
Mar. 31, 2020
Equity [Abstract]  
Equity Equity and Earnings Per Share
Common Stock
Dividends
On March 26, 2020, the Company paid a dividend of $0.79 per common share as part of a regular cash dividend program. During the three months ended March 31, 2020, the Company recorded $603 million as a distribution against retained earnings (of which $342 million related to the principal stockholder and his family and the remaining $261 million related to all other stockholders).
On March 28, 2019, the Company paid a dividend of $0.77 per common share as part of a regular cash dividend program. During the three months ended March 31, 2019, the Company recorded $595 million as a distribution against retained earnings (of which $333 million related to the principal stockholder and his family and the remaining $262 million related to all other shareholders).
In April 2020, the Company suspended the quarterly dividend program due to the impact of the COVID-19 Pandemic.
Noncontrolling Interests
On February 21, 2020, SCL paid a dividend of HKD 0.99 to SCL stockholders (a total of $1.03 billion, of which the Company retained $717 million during the three months ended March 31, 2020).
On February 22, 2019, SCL paid a dividend of HKD 0.99 to SCL stockholders (a total of $1.02 billion, of which the Company retained $716 million during the three months ended March 31, 2019).
On April 17, 2020, SCL announced it will not pay a final dividend for 2019 due to the impact of the COVID-19 Pandemic.
Earnings Per Share
Earnings Per Share
The weighted average number of common and common equivalent shares used in the calculation of basic and diluted earnings per share consisted of the following:

Three Months Ended
March 31,
 
2020
 
2019
 
(In millions)
Weighted-average common shares outstanding (used in the calculation of basic earnings per share)
764

 
774

Potential dilution from stock options and restricted stock and stock units

 
1

Weighted-average common and common equivalent shares (used in the calculation of diluted earnings per share)
764

 
775

Antidilutive stock options excluded from the calculation of diluted earnings per share
3

 
5